A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Since 1934, the Jewish General Hospital (JGH) has been providing cutting‑edge treatment and compassionate care to patients from diverse religious and cultural backgrounds in Montreal, throughout Quebec and beyond.
Montréal, Canada Clinical Trial Location
Jewish General Hospital
3755 Chemin de la Côte-Sainte-Catherine,
Montréal, QC H3T 1E2, Canada